Roche Breast-Cancer Treatment Falls Short of Primary Goal in Late-Stage Study

1 day ago 6
The operation of Roche’s investigational drug, giredestrant, with Pfizer’s Ibrance didn’t pb to a statistically important betterment among patients with precocious bosom cancer.
Read Entire Article
  1. Homepage
  2. Health
  3. Roche Breast-Cancer Treatment Falls Short of Primary Goal in Late-Stage Study

Related

Are more people cutting off their parents?

Are more people cutting off their parents?

9 hours ago 8
'I'm in constant pain' - woman harmed by vaginal mesh urges action on redress scheme

'I'm in constant pain' - woman harmed by vaginal mesh urges ...

16 hours ago 4
Wegovy maker Novo Nordisk said it is teaming up with Hims & Hers Health to sell its weight-loss drugs through the telehealth company’s platform

Wegovy maker Novo Nordisk said it is teaming up with Hims & ...

22 hours ago 4

Popular

Formula One comes to Apple TV: Everything you need to know about the new F1 2026 season

Formula One comes to Apple TV: Everything you need to know a...

4 days ago 26
Meta to Create New Applied AI Engineering Organization

Meta to Create New Applied AI Engineering Organization

6 days ago 23
Former Barclays Center Executive Says Live Nation Threatened to Pull Tours

Former Barclays Center Executive Says Live Nation Threatened...

5 days ago 22
Colorado Governor Signals He’ll Commute Sentence of Election Denier

Colorado Governor Signals He’ll Commute Sentence of Election...

5 days ago 20
Is He the Last Man in Naples, Italy, to Paint Numbers By Hand?

Is He the Last Man in Naples, Italy, to Paint Numbers By Han...

6 days ago 17
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved